Sector Update: Healthcare Shares Mixed; Ariad Rises 10% as Iclusig Approved for Leukemia Patients


Shutterstock photo

Healthcare stocks:

JNJ: flat

PFE: -0.16%

ABT: flat

MRK: -0.18%

AMGN: +0.11%

Healthcare shares are mixed in pre-market trade.

Among the movers in the sector, shares of Ariad Pharmaceuticals Inc. ( ARIA ) were up 10% in recent Monday premarket action, continuing the stock's climb after the European Medicines Agency's Committee for Human Medicinal Products adopted a positive view Friday on the continued use of the oncology company's Iclusig drug for patients with leukemia.

As the committee adopted the positive view Friday, it also made a series of recommendations on measures to help minimize the risk of occlusive vascular events. The recommendation means Iclusig can continue to be used in its approved indications in the EU following a review of updated safety data.

And, Clinical-stage biopharmaceutical company Dynavax Technologies Corporation ( DVAX ) is soaring about 6% after it was been upgraded by analysts at MLV & Co. to a Buy rating from a Hold. The firm boosted the price target on the stock more than four-fold to $5, from $1.50 a share.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities
More Headlines for: ARIA , DVAX

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by